Abstract
The mechanism of prolactin (PRL) unresponsiveness to repeated sulpiride (SUL) administration was investigated by means of two experimental protocols. The first one was carried on in seven male volunteers (age 24 to 34 yr) and consisted of two phases separated by a 5-day interval. In both phases 1 mg/kg of SUL was given im and repeated, 24 h later, together with either placebo (PL, 2 ml saline iv) or TRH (200 µg iv). 7–10 days later a standard TRH test (200 µg iv) was performed. In the second protocol the usual dose (1 mg/Kg im) of SUL was administered alone and, 24 h later, together with 0.1 U/Kg iv of insulin (insulin tolerance test: ITT) to six male volunteers (age 20 to 32 yr). A control standard ITT (0.1 U/Kg iv) was also performed 7–10 days later. Plasma samples for the evaluation of PRL were taken in basal conditions and at regular intervals after each drug administration. In the first protocol, PRL shQwed a significant increase (peak values at 30 min) after SUL administration in both phases (phase A: 54.8 ± 5.6 ng/ml, mean ± SE vs 6.4 ± 0.3, p < 0.001. Phase B: 77.5 ± 3.9 vs 7.0 ± 0.6, p < 0.001). Twenty-four h later, PRL levels were still higher than basal and were not affected by the administration of SUL + PL or SUL + TRH. Also in the second protocol, SUL alone induced a significant PRL increase (peak values at 30 min: 47.1 ± 7.2 vs 4.2 ± 0.5, p < 0.005). Twenty-four h later PRL levels were still higher than in basal conditions (12.4 ± 1.5, p < 0.01 vs day one) and were modified by SUL + ITT administration only mildly (at 60 min: 17.0 ± 2.8, p < 0.05 vs basal) and significantly less than what observed after SUL and insulin alone (p < 0.005, p < 0.05, respectively). SUL then seems to induce a prolonged unresponsiveness of pituitary PRL secreting cells to multiple administration apparently not overcome by different stimuli (TRH, ITT), probably due to an alteration distal to the dopamine receptor.
Similar content being viewed by others
References
McNeil L.W., McKenna T.J., Lacroix A., Benveniste R., Rabin D. Seventy-two hour infusions of LHRH in normal men: gonadotropin and testicular steroid responses. J. Clin. Endocrinol: Metab. 49: 149, 1979.
Rabin D., McNeil L.W. Pituitary and gonadal desensitization after continuous Luteinizing Hormone-Releasing Hormone infusion in normal females. J. Clin. Endocrinol. Metab. 51: 873, 1980.
Heber D., Swerdloff R.S. Down- regulation of pituitary gonadotropin secretion of postmenopausal females by continuous Gonadotropin-Releasing Hormone administration.. Clin. Endocrinol. Metab. 52: 171, 1981.
Bergquist C., Nillius S.J., Wide L. Reduced gonadotropin secretions in postmenopausal women during treatment with a stimulatory LHRH analog. J. Clin. Endocrinol. Metab. 49: 472, 1979.
Mongioj A., Aliffi A., Vicari E., Coniglione F., Scapagnini U., D’Agata R. Down-regulation of prolactin secretion in men during continuous thyrotropin-releasing hormone infusion: evidence for induction of pituitary desensitization by continuous TRH administration. J. Clin. Endocrinol: Metab. 56: 904, 1983.
Gelato M.C., D’Agata R., Pescovitz O., Loviaux D.L., Meniam G. Effect of continuous infusion of human growth hormone releasing factor (GRF) on GH in men. J. Endocrinol. Invest. 7(Suppl. 1): 5, 1984.
Webb C.B., Vance M., Thorner M.O., Perisutti G., Thominet J., Rivier J., Vale W., Frohman L.A. Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. J. Clin. Invest. 74: 96, 1984.
Creese I., Sibley D.R., Left S., Hamblin M. Dopamine receptors: subtypes, localization and regulation. Fed. Proc. 40: 147, 1981.
Cohen H., Pugeat M., Tourniaire J., Bertrand J. Unresponsiveness of prolactin to repeated injection of sulpiride in man. Eur. J. Clin. Pharmacol. 25: 275, 1983.
Justin-Besançon L., Thominet M., Laville C., Margarit J. Constitution chimique et propriétés biologiques du sulpiride. CR. Acad. Sci. Paris serie D. 265: 1253, 1967.
MacLeod R.M., Robyn C. Mechanism of increased prolactin secretion by sulpiride. J. Endocrinol. 72: 273, 1977.
Kebabian J.W., Calne D.B. Multiple receptors for dopamine. Nature 277: 93, 1979.
Sokoloff P., Martres M.P., Schwartz J.C. 3H-apomorphine lables both dopamine post-synaptic receptors and autoreceptors. Nature 288: 283, 1980.
Cote T.E., Crewe C.W., Tsuruta K., Stoof J.C., Esakay R.L., Kebabian J.W. D2 dopamine receptor-mediated inhibition of adenylate cyclase activity in the intermediate lobe of the rat pituitary gland requires guanosine 5′-triphosphate. Endocrinology 110: 812, 1982.
Besser G.M., Mortimer G.H. Clinical neuroendocrinology. In: Martini L., Ganong W.F. (Eds.) Frontiers in neuroendocrinology. Raven Press, New York, 1976, p. 227.
MacLeod R.M. Regulation of prolactin secretion. In: Martini L., Ganong W.F. (Eds.) Frontiers in neuroendocrinology. Raven Press, New York, 1976, p. 169.
Mancini A.M., Gutelman A., Vargas C.A., Debeljuk L., Aparicio N.J. Effect of sulpiride on serum PRL levels in humans. J. Clin. Endocrinol. Metab. 42: 181, 1976.
L’Hermite M., Denayer P., Goldstein J., Virasoro E., Wanhaelst L., Copinshi G., Robyn C. Acute endocrine profile of sulpiride in the human. Clin. Endocrinol. (Oxf.) 9: 195, 1978.
Jacobs L.S., Snyder P.J., Utiger R.D., Daughaday W.H. Prolactin response to thyrotropin-releasing hormone in normal subjects. J. Clin. Endocrinol. Metab. 36: 1069, 1973.
Porteus S.E., Malven P.V. Stimulation of prolactin release in vivo by thyrotropin-releasing hormone (TRH) through direct action in the ectopic rat pituitary. Endocrinology 94: 1699, 1974.
Murdoch G.H., Franco R., Evans R.M., Rosenfeld M.G. Polypeptide hormone regulation of gene expression. J. Biol. Chem. 258: 15329, 1983.
Tan K.N., Tashjian A.H. Voltage-dependent calcium channels in pituitary cells in culture. J. Biol. Chem. 259: 427, 1984.
Wilson R.G., Singhal V.K., Percy-Robb I., Forrest A.P.M. Response of plasma prolactin and growth hormone to insulin hypoglycemia. Lancet 2: 1283, 1972.
May P.B., Burrow G.N., Kayne R.D., Donabedian R.K. Hypoglycemia-induced prolactin release. Arch. Intern. Med. 138: 918, 1978.
Woolf P.D., Lee L.A., Leebaw W.F. Hypoglycemia as a provocative test of prolactin release. Metabolism 27: 869, 1978.
Buckman M.T., Peake G.T. Concordance of insulin-induced hypoglycemia and phenothiazine-induced prolactin secretion in man. J. Clin. Endocrinol. Metab. 48: 213, 1979.
Woolf P.D., Lee L.A., Leebaw W., Thompson D., Lilavivathana U., Brodows R., Campbell R. Intracellular glucopenia causes prolactin release in man. J. Clin. Endocrinol. Metab. 45: 377, 1977.
Prescott R.W.G., Kendall-Taylor T., Weightman D.R., Watson M.J., Ratcliffe W.A. The effect of ketanserin, a specific serotonin antagonist on the PRL, GH, ACTH and Cortisol responses to hypoglycemia in normal subjects. Clin. Endocrinol. (Oxf.) 20: 137, 1984.
Nathan R.S., Sachar E.J., Ostrow L., Asnis G.M., Halbreich U., Halpem F.S. Failure of dopaminergic blockade to affect prolactin, growth hormone, and Cortisol responses to insulin-induced hypoglycemia in schizophrenics. J. Clin. Endocrinol. Metab. 52: 807, 1981.
Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non carcinogenic chromogen. J. Clin. Pathol. 22: 158, 1969.
Pontiroli A.E., Gala R.R., Pellicciotta G., De Pasqua A., Giraddi A.M., Pozza G. Study on the reproducibility of human prolactin response to sulpiride, benzerazide, insulin hypoglycemia and arginine infusion. Acta Endocrinol. (Kbh.) 91: 410, 1979.
Tormey W.P., Buckley M.P., Taaffe W., O’Kelly D.A., Darragh A. Prolactin, responsiveness to repeated decrementai doses of sulpiride. Horm. Metab. Res. 13: 454, 1981.
Mongioì A., Vicari E., Macchi M. Dynamics of prolactin response during continuous sulpiride infusion: desensitization of dopaminergic receptor? J. Endocrinol. Invest. 7(Suppl. 1): 45, 1984.
Gasperi M., Pucci E., Ramacciotti C., Del Corso L., Beeli M., Monacci F., Luisi M., Franchi F. Valutazione della riserva ipofisaria di prolattina in età senile: stimolazione con metoclopramide. Giornale Geront. 33: 563, 1985.
Author information
Authors and Affiliations
Additional information
This work was supported by funds from the National Research Council, Rome, Italy: Progetto finalizzato Medicina Preventiva e Riabilitativa. Sottoprogetto: Meccanismi d’Invecchiamento.
Rights and permissions
About this article
Cite this article
Bernini, G.P., Gasperi, M., Gravina, G. et al. Prolactin unresponsiveness to repeated sulpiride administration in man: recent findings. J Endocrinol Invest 10, 131–135 (1987). https://doi.org/10.1007/BF03347175
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347175